Trial Outcomes & Findings for Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders (NCT NCT01099111)

NCT ID: NCT01099111

Last Updated: 2014-05-22

Results Overview

The entire mucosal microbial community were profiled using high-throughput DNA sequencing and microarray technology. The microarray approach is based on 16S rRNA gene targeted oligonucleotide allowing the rapid detection of thousands of DNA sequences simultaneously and thus constitutes an ideal tool to generate a comprehensive and holistic view of the gut microbial community in all participants of all study arms. Then they will be analysed between different colonic segments in each participant, pooled results of participants in each of the 5 arms will be compared to the measurable outcomes of other arms in general.

Recruitment status

COMPLETED

Target enrollment

225 participants

Primary outcome timeframe

1 - 2 weeks

Results posted on

2014-05-22

Participant Flow

Recruitment was conducted at KFMC (tertiary care medical center), starting 1/7/2010 and completed 29/9/2012. Demographic and clinical data were collected for all, together with performance of colonoscopy at entry and collection of samples as specified.

We were able to recruit the desired number for normal, IBS and UC groups. However, in view of strict inclusion and exclusion criteria, only 46 were recruited for CD and only 29 were recruited for CRC. Moreover, DNA extraction was not sufficient for some subjects at all groups that indicate replacing them with other patients.

Participant milestones

Participant milestones
Measure
Irritable Bowel Syndrome
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 08/05/2011, however, in view of insufficient DNA extraction of 5 subjects they have been replaced (on 28/07/2012) with other 5 subjects following exactly the same protocol. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Ulcerative Colitis
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 05/06/2012, however, in view of insufficient DNA extraction of 3 subjects they have been replaced on 16/09/2012 with other 3 subjects following exactly the same protocol. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Crohn's Disease
46 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 27/05/2012, however, in view of insufficient DNA extraction of 2 subjects they have been replaced on 05/09/2012 with other 2 subjects following exactly the same protocol. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Colo Rectal Cancer
29 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 28/05/2012, and all have been identified as sufficient DNA extraction. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Control: Normal Subjects
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 22/12/2010, however, in view of insufficient DNA extraction of 6 subjects they have been replaced on 19/09/2012 with other 6 subjects following exactly the same protocol. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Overall Study
STARTED
50
50
46
29
50
Overall Study
COMPLETED
50
50
46
29
50
Overall Study
NOT COMPLETED
0
0
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Irritable Bowel Syndrome
n=50 Participants
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 08/05/2011, however, in view of insufficient DNA extraction of 5 subjects they have been replaced (on 28/07/2012) with other 5 subjects following exactly the same protocol. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Ulcerative Colitis
n=50 Participants
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 05/06/2012, however, in view of insufficient DNA extraction of 3 subjects they have been replaced on 16/09/2012 with other 3 subjects following exactly the same protocol. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Crohn's Disease
n=46 Participants
46 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 27/05/2012, however, in view of insufficient DNA extraction of 2 subjects they have been replaced on 05/09/2012 with other 2 subjects following exactly the same protocol. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Colo Rectal Cancer
n=29 Participants
29 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 28/05/2012, and all have been identified as sufficient DNA extraction. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Control: Normal Subjects
n=50 Participants
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 22/12/2010, however, in view of insufficient DNA extraction of 6 subjects they have been replaced on 19/09/2012 with other 6 subjects following exactly the same protocol. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Total
n=225 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=93 Participants
4 Participants
n=4 Participants
11 Participants
n=27 Participants
0 Participants
n=483 Participants
0 Participants
n=36 Participants
15 Participants
n=10 Participants
Age, Categorical
Between 18 and 65 years
45 Participants
n=93 Participants
45 Participants
n=4 Participants
34 Participants
n=27 Participants
23 Participants
n=483 Participants
41 Participants
n=36 Participants
188 Participants
n=10 Participants
Age, Categorical
>=65 years
5 Participants
n=93 Participants
1 Participants
n=4 Participants
1 Participants
n=27 Participants
6 Participants
n=483 Participants
9 Participants
n=36 Participants
22 Participants
n=10 Participants
Age, Continuous
43.93 years
STANDARD_DEVIATION 14.505 • n=93 Participants
34.42 years
STANDARD_DEVIATION 12.586 • n=4 Participants
25.19 years
STANDARD_DEVIATION 10.672 • n=27 Participants
55.03 years
STANDARD_DEVIATION 10.137 • n=483 Participants
53.58 years
STANDARD_DEVIATION 12.747 • n=36 Participants
42.43 years
STANDARD_DEVIATION 12.71 • n=10 Participants
Sex: Female, Male
Female
31 Participants
n=93 Participants
34 Participants
n=4 Participants
24 Participants
n=27 Participants
14 Participants
n=483 Participants
32 Participants
n=36 Participants
135 Participants
n=10 Participants
Sex: Female, Male
Male
19 Participants
n=93 Participants
16 Participants
n=4 Participants
22 Participants
n=27 Participants
15 Participants
n=483 Participants
18 Participants
n=36 Participants
90 Participants
n=10 Participants
Region of Enrollment
Saudi Arabia
50 participants
n=93 Participants
50 participants
n=4 Participants
46 participants
n=27 Participants
29 participants
n=483 Participants
50 participants
n=36 Participants
225 participants
n=10 Participants

PRIMARY outcome

Timeframe: 1 - 2 weeks

Population: Each participant colonic mucosal microbiota populations pattern were analysed, and then compared to control to look for specific enrichments. If the DNA extract was not enough for sequencing, then the participant sample was excluded, however analysis calculation was based on all enrolled participants. The number analyzed here represent all enrolled

The entire mucosal microbial community were profiled using high-throughput DNA sequencing and microarray technology. The microarray approach is based on 16S rRNA gene targeted oligonucleotide allowing the rapid detection of thousands of DNA sequences simultaneously and thus constitutes an ideal tool to generate a comprehensive and holistic view of the gut microbial community in all participants of all study arms. Then they will be analysed between different colonic segments in each participant, pooled results of participants in each of the 5 arms will be compared to the measurable outcomes of other arms in general.

Outcome measures

Outcome measures
Measure
Irritable Bowel Syndrome
n=48 Participants
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 08/05/2011, however, in view of insufficient DNA extraction of 5 subjects they have been replaced (on 28/07/2012) with other 5 subjects following exactly the same protocol. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Ulcerative Colitis
n=48 Participants
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 05/06/2012, however, in view of insufficient DNA extraction of 3 subjects they have been replaced on 16/09/2012 with other 3 subjects following exactly the same protocol. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Crohn's Disease
n=34 Participants
46 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 27/05/2012, however, in view of insufficient DNA extraction of 2 subjects they have been replaced on 05/09/2012 with other 2 subjects following exactly the same protocol. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Colo Rectal Cancer
n=29 Participants
29 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 28/05/2012, and all have been identified as sufficient DNA extraction. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Control: Normal Subjects
n=49 Participants
50 subjects that exactly meet our inclusion \& exclusion criteria were recruited. Demographic and clinical data were entered for each during the introduction to the study and verifying acceptance to participate. Then after unified bowel preparation protocol, a full Colonoscopy was performed after signing the consent, during which mucosal washing samples were collected from the unified 4 colonic segment sites, as specified in methodology. Recruitment were completed on 22/12/2010, however, in view of insufficient DNA extraction of 6 subjects they have been replaced on 19/09/2012 with other 6 subjects following exactly the same protocol. Now, all are identified as sufficient DNA extraction and had been enrolled into a comprehensive analysis of the gastrointestinal tract microbiota and its contribution on gut homeostasis by using state of the art metagenomics technology.
Colonic-Mucosa Associated Microbial Species Per Compiled Participants in 5 Different Arms
40 microbial species population
Interval 4.0 to 190.0
30 microbial species population
Interval 9.0 to 190.0
23 microbial species population
Interval 17.0 to 189.0
23 microbial species population
Interval 20.0 to 197.0
41 microbial species population
Interval 41.0 to 41.0

Adverse Events

Irritable Bowel Syndrome

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Ulcerative Colitis

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Crohn's Disease

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Colo Rectal Cancer

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control: Normal Subjects

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Ahmed Al Omair

KFMC

Phone: +96612889999

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place